113 related articles for article (PubMed ID: 16995949)
1. In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model.
Morrone FB; Oliveira DL; Gamermann P; Stella J; Wofchuk S; Wink MR; Meurer L; Edelweiss MI; Lenz G; Battastini AM
BMC Cancer; 2006 Sep; 6():226. PubMed ID: 16995949
[TBL] [Abstract][Full Text] [Related]
2. The Effects of Methanol Extracts of Hyssopus officinalis on Model of Induced Glioblastoma Multiforme (GBM) in Rats.
Khaksar S; Kiarostami K; Alinaghi S
J Mol Neurosci; 2022 Sep; 72(9):2045-2066. PubMed ID: 35963984
[TBL] [Abstract][Full Text] [Related]
3. Effects of Glutamine Synthetase on Neovascularization in Glioma: In Vivo MR Vessel Size Imaging and Histology.
Song T; Wang D; Zhang Y; Hao H; Li G; Ding X; Hu Z; Zhang Z; Liu Y; Wang H; Li X; Qian J
Curr Med Imaging; 2024; 20(1):e15734056287859. PubMed ID: 38544393
[TBL] [Abstract][Full Text] [Related]
4. The role of thrombin in gliomas.
Hua Y; Tang L; Keep RF; Schallert T; Fewel ME; Muraszko KM; Hoff JT; Xi G
J Thromb Haemost; 2005 Sep; 3(9):1917-23. PubMed ID: 15975137
[TBL] [Abstract][Full Text] [Related]
5. Identification of proteins involved in neural progenitor cell targeting of gliomas.
Staflin K; Zuchner T; Honeth G; Darabi A; Lundberg C
BMC Cancer; 2009 Jun; 9():206. PubMed ID: 19558675
[TBL] [Abstract][Full Text] [Related]
6. Distribution of labelled anti-tenascin antibodies and fragments after injection into intact or partly resected C6-gliomas in rats.
Goetz CM; Rachinger W; Decker M; Gildehaus FJ; Stocker S; Jung G; Tatsch K; Tonn JC; Reulen HJ
Cancer Immunol Immunother; 2005 Apr; 54(4):337-44. PubMed ID: 15449040
[TBL] [Abstract][Full Text] [Related]
7. Possible effects of radiofrequency electromagnetic fields on in vivo C6 brain tumors in Wistar rats.
Ouadah NS; Lecomte A; Robidel F; Olsson A; Deltour I; Schüz J; Blazy K; Villégier AS
J Neurooncol; 2018 Dec; 140(3):539-546. PubMed ID: 30421158
[TBL] [Abstract][Full Text] [Related]
8. A liquid fraction of extracellular matrix inhibits glioma cell viability
Murdock MH; Hussey GS; Chang JT; Hill RC; Nascari DG; Rao AV; Hansen KC; Foley LM; Hitchens TK; Amankulor NM; Badylak SF
Oncotarget; 2022; 13():426-438. PubMed ID: 35198102
[TBL] [Abstract][Full Text] [Related]
9. Glioblastoma remodelling of human neural circuits decreases survival.
Krishna S; Choudhury A; Keough MB; Seo K; Ni L; Kakaizada S; Lee A; Aabedi A; Popova G; Lipkin B; Cao C; Nava Gonzales C; Sudharshan R; Egladyous A; Almeida N; Zhang Y; Molinaro AM; Venkatesh HS; Daniel AGS; Shamardani K; Hyer J; Chang EF; Findlay A; Phillips JJ; Nagarajan S; Raleigh DR; Brang D; Monje M; Hervey-Jumper SL
Nature; 2023 May; 617(7961):599-607. PubMed ID: 37138086
[TBL] [Abstract][Full Text] [Related]
10. Retroviral transfer of the p16INK4a cDNA inhibits C6 glioma formation in Wistar rats.
Strauss BE; Fontes RB; Lotfi CF; Skorupa A; Bartol I; Cipolla-Neto J; Costanzi-Strauss E
Cancer Cell Int; 2002 Apr; 2(1):2. PubMed ID: 11983028
[TBL] [Abstract][Full Text] [Related]
11. Suramin increased telomerase activity in the c6 glioma/wistar experimental brain tumor model.
Ergüven M; Bilir A; Altug T; Aktar F; Akev N
Int J Biomed Sci; 2007 Jun; 3(2):104-11. PubMed ID: 23675031
[TBL] [Abstract][Full Text] [Related]
12. Effect of Naringenin on metabolic markers, lipid profile and expression of GFAP in C6 glioma cells implanted rat's brain.
Devan S; Janardhanam VA
Ann Neurosci; 2011 Oct; 18(4):151-5. PubMed ID: 25205946
[TBL] [Abstract][Full Text] [Related]
13. Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistance.
Aria H; Rezaei M; Nazem S; Daraei A; Nikfar G; Mansoori B; Bahmanyar M; Tavassoli A; Vakil MK; Mansoori Y
Front Immunol; 2022; 13():947885. PubMed ID: 36072596
[TBL] [Abstract][Full Text] [Related]
14. P2Y
Vargas P; Scheffel TB; Diz FM; Rockenbach L; Grave N; Cappellari AR; Kist LW; Bogo MR; Thomé MP; Leal GF; de Fraga Dias A; Figueiró F; Filippi-Chiela EC; Lenz G; Morrone FB
Purinergic Signal; 2022 Dec; 18(4):481-494. PubMed ID: 35939198
[TBL] [Abstract][Full Text] [Related]
15. Extracellular ATP promotes angiogenesis and adhesion of TNBC cells to endothelial cells via upregulation of CTGF.
Zhou YT; Yu YQ; Yang H; Yang H; Huo YF; Huang Y; Tian XX; Fang WG
Cancer Sci; 2022 Jul; 113(7):2457-2471. PubMed ID: 35441763
[TBL] [Abstract][Full Text] [Related]
16. P2X7 receptor: the regulator of glioma tumor development and survival.
Matyśniak D; Chumak V; Nowak N; Kukla A; Lehka L; Oslislok M; Pomorski P
Purinergic Signal; 2022 Mar; 18(1):135-154. PubMed ID: 34964926
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Microglia Activation and Glioma Tumor Progression by Inflammagen Priming in Mice with Tumor Necrosis Factor Receptor Type 2 Deficiency.
Liao CK; Fang KM; Huang HT; Chang WR; Chuang CC; Tzeng SF
Life (Basel); 2021 Sep; 11(9):. PubMed ID: 34575110
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance and combating drug resistance in cancer.
Wang X; Zhang H; Chen X
Cancer Drug Resist; 2019; 2(2):141-160. PubMed ID: 34322663
[TBL] [Abstract][Full Text] [Related]
19. Ectonucleotidases in Inflammation, Immunity, and Cancer.
Haas CB; Lovászi M; Braganhol E; Pacher P; Haskó G
J Immunol; 2021 May; 206(9):1983-1990. PubMed ID: 33879578
[TBL] [Abstract][Full Text] [Related]
20. Role of Purinome, A Complex Signaling System, In Glioblastoma Aggressiveness.
Giuliani P; Carluccio M; Ciccarelli R
Front Pharmacol; 2021; 12():632622. PubMed ID: 33613296
[No Abstract] [Full Text] [Related]
[Next] [New Search]
